CGI's Buyback-Driven EPS Growth Underscores Valuation Support

What happened

CGI's adjusted EPS rose 9% but organic growth remains muted, with the increase primarily attributed to aggressive share repurchases. Federal revenue has turned positive, hiring is accelerating, and the pipeline for managed services and AI opportunities is expanding, signaling early signs of demand recovery. At ~16x P/E with a DCF value of ~$142 per share versus a price around $89, the market appears to discount limited growth expectations despite CGI's durable free cash flow and strong balance sheet (net debt/EBITDA 0.64x). The company's sticky public-sector and regulated-industry relationships, combined with its global delivery scale, position it to benefit from AI-driven modernization and UK/EU public-sector digitization. Key risks include execution in competitive UK/EU frameworks and EU AI Act compliance burdens, but CGI's track record of per-share value creation supports a favorable risk-reward.

Implication

The recent buyback-driven EPS growth, while not organic, reduces share count and enhances per-share metrics, which is accretive if cash flows remain stable. The positive turn in federal revenue and accelerating hiring suggest that management sees improving demand, which could translate into organic growth in coming quarters. With the stock trading at a ~38% discount to the DCF value, the market has priced in a prolonged growth stagnation, offering a margin of safety for patient investors. However, investors should monitor whether the AI pipeline and managed services wins materialize into revenue, as continued reliance on buybacks without organic growth could compress the multiple. Overall, the BUY rating remains supported by valuation and financial strength, but the next few quarters will be critical to confirm the anticipated growth inflection.

Thesis delta

The thesis remains BUY, but the article highlights that recent EPS growth is largely due to buybacks rather than organic expansion. This underscores the importance of the anticipated pickup in federal revenue and AI pipeline to sustain the valuation. No material change to the long-term valuation-based BUY case, but increased monitoring of organic growth metrics is warranted.